To investigate the effect of LAG3 on cervical cancer cell biology, we first optimized the dose–response of siLAG3 transfection in Hela and Siha cells and verified the overexpression efficiency of the LAG3 plasmid. The gene discussed is LAG3; the disease is cervical cancer.